Group III metabotropic glutamate receptor agonists selectively suppress excitatory synaptic currents in the rat prefrontal cortex induced by 5-hydroxytryptamine2A receptor activation

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 1, 2007, Pages 437-447

  Zhang, Ce ^a   Marek, Gerard J ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 2 METHYL 4 PHOSPHONOBUTYRIC ACID; 4 PHOSPHONOPHENYLGLYCINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ALPHA CYCLOPROPYL 4 PHOSPHONOPHENYLGLYCINE; AMINOBUTYRIC ACID DERIVATIVE; LEVO 4 PHOSPHONO 2 AMINOBUTYRIC ACID; LEVO SERINE O PHOSPHATE; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; NONHUMAN; PREFRONTAL CORTEX; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; STEADY STATE; WHITE MATTER;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; AMINO ACIDS; ANIMALS; BICYCLO COMPOUNDS; GLYCINE; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, METABOTROPIC GLUTAMATE; SEROTONIN; SYNAPTIC TRANSMISSION; XANTHENES;

EID: 33845908795     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.107490     Document Type: Article

References (40)

1. Aghajanian GK and Marek GJ (1999) Serotonin-glutamate interactions: a new target for antipsychotic drugs. Neuropsychopharmacology 21:S122-S133.
2. Aghajanian GK and Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589-599.
3. Berendse HW and Groenewegen HJ (1991) Restricted cortical termination fields of the midline and intralaminar thalamic nuclei in the rat. Neuroscience 42:73-102.
4. 2 receptors and serotonergic axons in rat neocortex. Brain Res 453:315-328.
5. Corti C, Aldegheri L, Somogyi P, and Ferraguti F (2002) Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. Neuroscience 110:403-420.
6. De Colle C, Bessis A-S, Bockaert J, Archer F, and Pin J-P (2000) Pharmacological characterization of the rat metabotropic glutamate receptor type 8a revealed strong similarities and slight differences with the type 4a receptor. Eur J Pharmacol 394:17-26.
7. Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, Laurie D, Sommer B, Varney MA, Hess SD, et al. (1999) (R,S)-4- phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J Pharmacol Exp Ther 289:1678-1687.
8. Ghauri M, Chapman AG, and Meldrum BS (1996) Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs. Neuroreport 7:1469-1474.
9. Han G and Hampson DR (1999) Ligand binding to the amino-terminal domain of the mGluR4 subtype of metabotropic receptor. J Biol Chem 274:10008-10013.
10. Jin X and Daw NW (1998) The group III metabotropic glutamate receptor agonist L-AP4, reduces EPSPs in some layers of rat visual cortex. Brain Res 797:218-224.
11. Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Belagaje R, Wu S, and Schoepp DD (1998) LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37:1-12.
12. Knopfel T, Lukic S, Leonardt T, Flor PJ, Kuhn R, and Gasparini F (1995) Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and mGluR4a human metabotropic glutamate receptor subtypes. Neuropharmacology 34:1099-1102.
13. Kosinski CM, Bradley SR, Conn PJ, Levey AI, Landwehrmeyer GB, Penney JB Jr, Young AB, and Standaert DG (1999) Localization of metabotropic glutamate receptor 7 mRNA and mGlu7a protein in the rat basal ganglia. J Comp Neurol 415:266-284.
14. Lambe EK and Aghajanian GK (2001) The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex. J Neurosci 21:9955-9963.
15. Lambe EK and Aghajanian GK (2003) Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 40:139-150.
16. Lovinger DM and McCool BA (1995) Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGluR2 or 3. J Neurophysiol 73:1076-1083.
17. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, and Watson SJ (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350:412-438.
18. Marek GJ and Aghajanian GK (1998) 5-HT-induced EPSCs in neocortical layer V pyramidal cells: suppression by μ-opiate receptor activation. Neuroscience 86:485-497.
19. 1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol 367:197-206.
20. 2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28:402-412.
21. Marek GJ, Wright RA, Gewirtz JC, and Schoepp DD (2001) A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in neocortex. Neuroscience 105:113-126.
22. 2A and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292:76-87.
23. McCormick DA, Connors BW, Lighthall JW, and Prince DA (1985) Comparative electrophysiology of pyramidal and sparsely spiny neurons of the neocortex. J Neurophysiol 54:782-806.
24. Moghaddam B and Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonists in rats. Science (Wash DC) 281:1349-1352.
25. Muschamp JW, Regina MJ, Hull EM, Winter JC, and Rabin RA (2004) Lysergic acid diethylamide and (-)-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Res 1023:134-140.
26. 3H]CPPG. Neuropharmacology 40:170-177.
27. Neto FL, Schadrack J, Berthele A, Zieglgansberger W, Tolle TR, and Castro-Lopes JM (2000) Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat. Brain Res 854:93-105.
28. Ohishi H, Akazawa C, Shigemoto R, Nakanishi S, and Mizuno N (1995) Distributions of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain. J Comp Neurol 360:555-570.
29. Ohishi H, Shigemoto R, Nakanishi S, and Mizuno N (1993) Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53:1009-1018.
30. Phillips T, Makoff A, Brown S, Rees S, and Emson P (1997) Localization of mGluR4 protein in the rat cerebral cortex and hippocampus. Neuroreport 8:3349-3354.
31. Pisani A, Calabresi P, Centonze D, and Bernardi G (1997) Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapses. Neuropharmacology 36:845-851.
32. Saugstad JA, Kinzie JM, Shinohara MM, Segerson TP, and Westbrook GL (1997) Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile. J Pharmacol Exp Ther 51:119-125.
33. Schoepp DD, Jane DE, and Monn JA (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38:1431-1476.
34. 2A heteroceptors on thalamocortical glutamatergic neurons. J Neurosci 20:8846-8852.
35. Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ, Neki A, Abe T, Nakanishi S, et al. (1997) Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci 17:7503-7522.
36. Thomas NK, Wright RA, Howson PA, Kingston AE, Schoepp DD, and Jane DE (2001) (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology 40:311-318.
37. Turner JP and Salt TE (1999) Group III metabotropic glutamate receptors control corticothalamic synaptic transmission in the rat thalamus in vitro. J Physiol 519.2:481-491.
38. Vollenweider FX, Vollenweider-Scherpenhuyzen MFI, Babler A, Vogel H, and Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9:3897-3902.
39. 3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 362:546-554.
40. Zhang C and Marek GJ (2000) AMPA receptors mediate serotonin-2A receptor-induced EPSCs in layer V pyramidal cells of prefrontal cortex. Soc Neurosci Abstr 26:1427.